NEW YORK, Aug. 17 /PRNewswire-FirstCall/ -- Pink OTC Markets Inc. (OTCQX: PINK), the financial information and technology services company that operates the leading electronic quotation and trading system in the U.S. OTC securities market, today announced that CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM), a Canadian-based medical technology company, is now trading on the OTC market's highest tier, OTCQX®.
CRH Medical began trading today on the OTC market's prestigious tier, OTCQX International. Investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcqx.com and www.otcmarkets.com.
"OTCQX companies demonstrate their commitment to providing superior information to investors and maintaining the highest quality standards," said R. Cromwell Coulson, President and CEO of Pink OTC Markets. "We are pleased to welcome CRH Medical to OTCQX."
Berenbaum Weinshienk PC will serve as CRH Medical's Principal American Liaison ("PAL") on OTCQX, responsible for providing guidance on OTCQX requirements.
About CRH Medical Corp.
CRH Medical Corp. (OTCQX: CRMMF, TSX.V: CRM) specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I – IV. CRH employs two commercialization strategies: first, CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, turnkey package directl
|SOURCE Pink OTC Markets Inc.|
Copyright©2010 PR Newswire.
All rights reserved